MedTrace Logo

A Non-Invasive Neuromodulation Device for Treatment of Migraine Headache

NCT01899040 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2025-05-31

Study results available
· View outcomes & findings →

Summary

This is a randomized, blinded study designed to assess the efficacy of a portable, non-invasive neuromodulation system for the treatment of episodic migraine headaches.

Conditions

  • Migraine Headache, Episodic

Interventions

DEVICE

neuromodulation for episodic migraine headache

Sponsors & Collaborators

  • Scion NeuroStim

    lead INDUSTRY

Principal Investigators

  • Lesco Rogers, MD · Scion NeuroStim

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-08-31
Primary Completion
2016-05-31
Completion
2016-06-30

Countries

  • United States
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01899040 on ClinicalTrials.gov